ACCESS INDUSTRIES, LLC - 30 Sep 2025 SCHEDULE 13D/A Report for MediWound Ltd. Ordinary Shares, par value NIS 0.07 per share (MDWD)

Filing Manager
ACCESS INDUSTRIES, LLC
Reporting Manager
Access Industries Holdings LLC
Security
MediWound Ltd. Ordinary Shares, par value NIS 0.07 per share
Symbol
MDWD
Shares outstanding
12,815,926 shares
Disclosed Ownership
1,481,521 shares
Ownership
12%
Form type
SCHEDULE 13D/A
Filing time
03 Oct 2025, 21:30:03 UTC
Date of event
30 Sep 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"ACCESS INDUSTRIES, LLC disclosed 12% ownership in MediWound Ltd. Ordinary Shares, par value NIS 0.07 per share (MDWD) on 30 Sep 2025."

Quick Takeaways

  • ACCESS INDUSTRIES, LLC filed SCHEDULE 13D/A for MediWound Ltd. Ordinary Shares, par value NIS 0.07 per share (MDWD).
  • Disclosed ownership: 12%.
  • Date of event: 30 Sep 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 03 Oct 2025, 21:30.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (7)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Access Industries Holdings LLC 12% 1,481,521 0 1,481,521 /s/ Alejandro Moreno By: Access Industries Management, LLC, its manager; its Executive Vice President, General Counsel/Alejandro Moreno 0001391297
Access Industries, LLC 12% 1,481,521 0 1,481,521 /s/ Alejandro Moreno By: Access Industries Management, LLC, its manager; its Executive Vice President, General Counsel/Alejandro Moreno 0001508227
Access Industries Management, LLC 12% 1,481,521 0 1,481,521 /s/ Alejandro Moreno Executive Vice President, General Counsel/Alejandro Moreno 0001508226
Clal Industries Ltd. 12% 1,481,521 0 1,481,521 /s/ Alon Heller VP Finance/Alon Heller 0001051856
Clal Biotechnology Industries Ltd. 12% 1,481,521 308,811 1,172,710 /s/ Nufar Malovani Director/Nufar Malovani 0001468950
Clal Life Sciences L.P. 9.2% 1,172,710 1,172,710 0 /s/ Nufar Malovani Director/Nufar Malovani
Len Blavatnik 12% 1,481,521 0 1,481,521 */s/ Alejandro Moreno By: Alejandro Moreno as Attorney-in-Fact for Len Blavatnik 0001326628

Sponsored